Aclaris Therapeutics Inc. added Andrew Schiff to its board.
Schiff is a managing partner at Aisling Capital LLC.
Discover more about S&P Global’s offerings
Aclaris Therapeutics adds director
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
Aclaris Therapeutics Inc. added Andrew Schiff to its board.
Schiff is a managing partner at Aisling Capital LLC.